| Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized … S Rögnvaldsson, TJ Love, S Thorsteinsdottir, ER Reed, JÞ Óskarsson, ... Blood cancer journal 11 (5), 1-13, 2021 | 69 | 2021 |
| Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents … SY Kristinsson, S Rögnvaldsson, S Thorsteinsdottir, ER Reed, ... Blood 138, 156, 2021 | 17 | 2021 |
| Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study S Rognvaldsson, E Eythorsson, S Thorsteinsdottir, B Vidarsson, ... Blood cancer journal 11 (12), 1-6, 2021 | 7 | 2021 |
| Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population-Based on Iceland Screens Treats or Prevents … TE Long, OS Indridason, R Palsson, S Rögnvaldsson, TJ Love, ... Blood 138, 542, 2021 | 4 | 2021 |
| Monitoring of Circulating Tumor Plasma Cells in Patients with Precursor Conditions of Multiple Myeloma: Data from the Prospective Iceland Screens, Treats, or Prevents Multiple … JÞ Óskarsson, I Petursdottir, S Rögnvaldsson, S Thorsteinsdottir, ... Blood 138, 2645, 2021 | 2 | 2021 |
| Estimating Selection Bias in Previous Monoclonal Gammopathy of Undetermined Significance Research-the Importance of Screening: Results from the Population-Based Screening Study … AÝ Sigurbergsdóttir, S Rögnvaldsson, S Thorsteinsdottir, IS Sverrisdottir, ... Blood 138, 1618, 2021 | 1 | 2021 |
| Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM) S Rögnvaldsson, E Eythorsson, S Thorsteinsdottir, B Vidarsson, ... Blood 138, 154, 2021 | | 2021 |
